Adam Thorpe joins Stax as managing director

27 February 2025 Consultancy.uk

Global strategy consulting firm Stax has appointed Adam Thorpe as a managing director in its London office. Thorpe brings more than three decades of knowhow to the firm.

Thorpe said, “What drew me to Stax is its focused, value-driven approach to working with private equity and corporate clients – leveraging data, insights, and industry expertise to deliver robust commercial and strategic advice across targeted industry verticals. I’m eager to contribute to the firm’s growth and the continued expansion of our healthcare practice.”

Stax is a global strategy consulting firm specialising in commercial due diligence, value creation, and exit planning for private equity firms, PE-backed companies, hedge funds, and investment banks. In recent years, the firm has been ramping up its offering in the UK – the world’s second largest national consulting market – through organic growth and acquisitions.

In 2022, US-headquartered Stax purchased AMR International – with offices in London, Paris and New York. Meanwhile, last year the consultancy also opened a new office in Central London, as it sought to forge stronger ties with European clients.

In his new role at the firm, Thorpe will lead the firm’s EMEA healthcare vertical. With significant experience advising investors and navigating the complexities of UK and European health and life sciences, he will help the practice to grow its market share on both sides of the Atlantic.

With 30 years of professional experience under his belt, Thorpe has dedicated the past two decades to specialising in the healthcare and care sectors. He has guided clients on deals and growth initiatives, including commercial due diligence and value creation across the deal cycle, helping them achieve accelerated growth and enhanced performance.

Before joining Stax, he established and led KPMG’s French strategy group practice from 2000 to 2015. He later returned to KPMG UK to head deal strategy in healthcare before departing the firm in 2024. During his career, Adam has gained extensive expertise in health, care, and life sciences, working across care types such as home, aged, child, and specialist care, and diverse segments including mental health, neurodiversity, diagnostics, education, medical devices, CDMO, and pharma.

“Adam brings exceptional leadership and sector expertise to the team, making him a standout addition to Stax,” added Phil Dunne, UK managing director of Stax. “His experience spans the multifaceted healthcare sector—from providers and the NHS to pharma, MedTech, community care, and even veterinary service. Combined with his strong tech perspective, Adam is uniquely positioned to address the diverse needs of our clients and drive Stax’s continued growth.”